20 citations
,
July 1988 in “Clinics in dermatology”
This article reviews the current practices and interpretations of research data on permanent waving and hair straightening, but does not present any new research findings.
1 citations
,
April 2013 in “Pakistan Journal of Biological Sciences”
This study found that hair coloring, waving, and ironing were associated with increased hair abnormalities compared to untreated hair in Iranian women.
This study observed that repeated perm treatments decrease disulfide bonds in hair due to their conversion largely into cysteic acid, affecting the waving efficiency depending on the reduction agent used.
This systematic review found no existing studies evaluating the effectiveness of waxing and mechanical epilation as methods of preoperative hair removal to reduce surgical site infections, highlighting a potential area for future research.
Unwanted hair growth from minoxidil use, with suggestions to reduce dosage or switch to finasteride. Users recommend hair removal methods like shaving, waxing, or electrolysis to manage excess facial hair.
The user stabilized hair loss with oral finasteride, dutasteride, and topical minoxidil, and underwent a stem cell and PRP procedure. Recent increased hair shedding may be due to restarting dermarolling, affecting minoxidil absorption, or the waning effects of the stem cell treatment.
Finasteride mainly prevents further hair loss by blocking DHT but doesn't reverse existing damage, while minoxidil can promote regrowth by waking dormant follicles. Ketoconazole helps with inflammation, but none of these treatments can reverse fibrosis or structural changes around hair follicles.
Minoxidil use led to excessive eyebrow and forehead hair growth, prompting grooming advice like waxing, tweezing, and shaving. Some suggested reducing dosage or considering electrolysis for permanent hair removal.
Hair follicles are mostly dormant but can be reactivated with treatments like minoxidil, finasteride, and microneedling. A new drug, PP405, shows promise for hair regrowth but may not be available until 2027-2028.
Did you know PP405 peptides can help protect your follicles from DHT?PP405 is not a peptide and does not block DHT: it is an experimental topical gel from Pelage Pharmaceuticals that inhibits the mitochondrial pyruvate carrier, aimed at waking dormant follicles. Its registered Phase 2 trial (NCT06393452) measured safety and tolerability in 78 adults with pattern hair loss; it is not approved and not for sale.
Hair transplantation moves DHT-resistant follicles from a donor area (back and sides of the scalp) into thinning or bald areas. The transplanted hair is generally permanent, though surrounding native hair can keep thinning.